Getty Images has initiated a prepackaged Chapter 11 bankruptcy process to implement a financial restructuring plan that includes up to $533 million in equity investment from the Getty family and Koch Equity Development. This move aims to significantly reduce the company's debt and resolve non-operating legal liabilities, strengthening its balance sheet for future growth. The restructuring will not affect daily operations, employees, customers, or partners, and Getty Images plans to complete the process by year-end to emerge as a privately held company. The company will continue normal business activities throughout the process, supported by major stakeholders and secured financing.
Getty Images' financial restructuring is the focus here, with Pluang providing market context for media stocks. For readers following media-sector US stocks, here is Pluang's market snapshot as of Oct 21, 2026 12:11 WIB: Out of 58 priced stocks, 41 rose and 13 fell. Notable movers include FOXA at USD 67.79 with a 3.86% increase and 80% buy order activity, ANGI at USD 6.47 up 3.43%, and ZG at USD 32.89 up 3.36% but with 88% sell order activity.
A webinar titled "Ready for AI?" scheduled for October 29, 2026, will discuss how artificial intelligence is reshaping public relations by changing how information is found, evaluated, and shared. Experts will share insights on maintaining message vi...
17a-4 LLC introduced DataParser Hub, an API that enables clients to integrate proprietary messaging and collaboration data into Microsoft 365 Purview and Copilot. This solution supports over 30 data types from platforms like Slack, Zoom, and Webex, a...
IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...
IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...
WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...
